284 related articles for article (PubMed ID: 9260738)
1. Blood-retinal barrier (BRB) breakdown in experimental autoimmune uveoretinitis: comparison with vascular endothelial growth factor, tumor necrosis factor alpha, and interleukin-1beta-mediated breakdown.
Luna JD; Chan CC; Derevjanik NL; Mahlow J; Chiu C; Peng B; Tobe T; Campochiaro PA; Vinores SA
J Neurosci Res; 1997 Aug; 49(3):268-80. PubMed ID: 9260738
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease.
Vinores SA; Youssri AI; Luna JD; Chen YS; Bhargave S; Vinores MA; Schoenfeld CL; Peng B; Chan CC; LaRochelle W; Green WR; Campochiaro PA
Histol Histopathol; 1997 Jan; 12(1):99-109. PubMed ID: 9046048
[TBL] [Abstract][Full Text] [Related]
3. The blood-retinal barrier in experimental autoimmune uveoretinitis. Leukocyte interactions and functional damage.
Greenwood J; Howes R; Lightman S
Lab Invest; 1994 Jan; 70(1):39-52. PubMed ID: 8302017
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of protein kinase C decreases prostaglandin-induced breakdown of the blood-retinal barrier.
Saishin Y; Saishin Y; Takahashi K; Melia M; Vinores SA; Campochiaro PA
J Cell Physiol; 2003 May; 195(2):210-9. PubMed ID: 12652648
[TBL] [Abstract][Full Text] [Related]
5. Electron microscopic immunocytochemical evidence for the mechanism of blood-retinal barrier breakdown in galactosemic rats and its association with aldose reductase expression and inhibition.
Vinores SA; Van Niel E; Swerdloff JL; Campochiaro PA
Exp Eye Res; 1993 Dec; 57(6):723-35. PubMed ID: 8150024
[TBL] [Abstract][Full Text] [Related]
6. Increased vascular endothelial growth factor (VEGF) and transforming growth factor beta (TGFbeta) in experimental autoimmune uveoretinitis: upregulation of VEGF without neovascularization.
Vinores SA; Chan CC; Vinores MA; Matteson DM; Chen YS; Klein DA; Shi A; Ozaki H; Campochiaro PA
J Neuroimmunol; 1998 Aug; 89(1-2):43-50. PubMed ID: 9726824
[TBL] [Abstract][Full Text] [Related]
7. Quantitative assessment of the integrity of the blood-retinal barrier in mice.
Derevjanik NL; Vinores SA; Xiao WH; Mori K; Turon T; Hudish T; Dong S; Campochiaro PA
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2462-7. PubMed ID: 12091451
[TBL] [Abstract][Full Text] [Related]
8. VEGF164 is proinflammatory in the diabetic retina.
Ishida S; Usui T; Yamashiro K; Kaji Y; Ahmed E; Carrasquillo KG; Amano S; Hida T; Oguchi Y; Adamis AP
Invest Ophthalmol Vis Sci; 2003 May; 44(5):2155-62. PubMed ID: 12714656
[TBL] [Abstract][Full Text] [Related]
9. The effect of TNF-alpha and IL-6 on the permeability of the rat blood-retinal barrier in vivo.
Bamforth SD; Lightman S; Greenwood J
Acta Neuropathol; 1996; 91(6):624-32. PubMed ID: 8781662
[TBL] [Abstract][Full Text] [Related]
10. Leukocyte diapedesis in vivo induces transient loss of tight junction protein at the blood-retina barrier.
Xu H; Dawson R; Crane IJ; Liversidge J
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2487-94. PubMed ID: 15980240
[TBL] [Abstract][Full Text] [Related]
11. An adenosine agonist and prostaglandin E1 cause breakdown of the blood-retinal barrier by opening tight junctions between vascular endothelial cells.
Vinores SA; Sen H; Campochiaro PA
Invest Ophthalmol Vis Sci; 1992 May; 33(6):1870-8. PubMed ID: 1582791
[TBL] [Abstract][Full Text] [Related]
12. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas.
Murata T; Nakagawa K; Khalil A; Ishibashi T; Inomata H; Sueishi K
Lab Invest; 1996 Apr; 74(4):819-25. PubMed ID: 8606491
[TBL] [Abstract][Full Text] [Related]
13. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
[TBL] [Abstract][Full Text] [Related]
14. Ultrastructural studies of the blood-retina barrier after exposure to interleukin-1 beta or tumor necrosis factor-alpha.
Claudio L; Martiney JA; Brosnan CF
Lab Invest; 1994 Jun; 70(6):850-61. PubMed ID: 8015289
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of vascular endothelial growth factor (VEGF) in the retinas of transgenic mice overexpressing interleukin-1beta (IL-1beta) in the lens and mice undergoing retinal degeneration.
Vinores SA; Xiao WH; Zimmerman R; Whitcup SM; Wawrousek EF
Histol Histopathol; 2003 Jul; 18(3):797-810. PubMed ID: 12792892
[TBL] [Abstract][Full Text] [Related]
16. Quantitative MR imaging study of intravitreal sustained release of VEGF in rabbits.
Alikacem N; Yoshizawa T; Nelson KD; Wilson CA
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1561-9. PubMed ID: 10798677
[TBL] [Abstract][Full Text] [Related]
17. Ultrastructural analysis of interleukin-1 beta-induced leukocyte recruitment to the rat retina.
Bamforth SD; Lightman SL; Greenwood J
Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):25-35. PubMed ID: 9008627
[TBL] [Abstract][Full Text] [Related]
18. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group.
Antonetti DA; Barber AJ; Khin S; Lieth E; Tarbell JM; Gardner TW
Diabetes; 1998 Dec; 47(12):1953-9. PubMed ID: 9836530
[TBL] [Abstract][Full Text] [Related]
19. Ultrastructural localization of blood-retinal barrier breakdown in diabetic and galactosemic rats.
Vinores SA; McGehee R; Lee A; Gadegbeku C; Campochiaro PA
J Histochem Cytochem; 1990 Sep; 38(9):1341-52. PubMed ID: 2117624
[TBL] [Abstract][Full Text] [Related]
20. Cellular mechanisms of blood-retinal barrier dysfunction in macular edema.
Vinores SA; Derevjanik NL; Ozaki H; Okamoto N; Campochiaro PA
Doc Ophthalmol; 1999; 97(3-4):217-28. PubMed ID: 10896335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
